Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-23

Clinical Trial Update: Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue [Phase 2]

View source ↗

Summary

This Phase 2 trial update compares Organic Germanium to placebo for preventing radiation-induced fatigue in patients with localized breast or prostate cancer re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Organic Germanium (Ge-132) (organic germanium compound)

Snippet

Sponsor: Arizona Oncology Services | Conditions: Localized Breast Cancer, Localized Prostate Cancer | Phase 2 | Status: UNKNOWN